Cita APA (7a ed.)

Abdelhamid, A. M., Saber, S., Youssef, M. E., Gaafar, A. G. A., Eissa, H., Abd-Eldayem, M. A., . . . El-Fattah, E. E. A. (2022). Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application. Elsevier.

Cita Chicago Style (17a ed.)

Abdelhamid, Amir Mohamed, et al. Empagliflozin Adjunct with Metformin for the Inhibition of Hepatocellular Carcinoma Progression: Emerging Approach for New Application. Elsevier, 2022.

Cita MLA (8a ed.)

Abdelhamid, Amir Mohamed, et al. Empagliflozin Adjunct with Metformin for the Inhibition of Hepatocellular Carcinoma Progression: Emerging Approach for New Application. Elsevier, 2022.